Thalamic Dysconnectivity Seen in Those at Risk for Psychosis

This article originally appeared here.
Share this content:
Thalamic Dysconnectivity Seen in Those at Risk for Psychosis
Thalamic Dysconnectivity Seen in Those at Risk for Psychosis

WEDNESDAY, Aug. 12, 2015 (HealthDay News) -- Among individuals at clinical high risk for psychosis, thalamic dysconnectivity is evident, according to a study published online Aug. 12 in JAMA Psychiatry.

In a multicenter, two-year follow-up case-control study, Alan Anticevic, Ph.D., from the Yale University School of Medicine in New Haven, Conn., and colleagues examined whether thalamocortical connectivity is altered in individuals at risk for psychosis. Data were included for 243 individuals at clinical high risk of psychosis, of whom 21 converted to full-blown illness, and 154 healthy controls (all aged 12 to 35 years).

The researchers identified thalamocortical dysconnectivity among individuals at clinical high risk for psychosis, which was particularly pronounced in the participants who converted to full-blown illness. Widespread hypoconnectivity was seen between the thalamus and prefrontal and cerebellar areas; the pattern was more prominent among those who converted to full-blown illness. Marked thalamic hyperconnectivity was seen in sensory motor areas, which was also most pronounced among those who converted to full-blown illness. Significant correlations were seen for both patterns with concurrent prodromal symptom severity.

"Dysconnectivity correlated with symptom severity, supporting the idea that thalamic connectivity may have prognostic implications for risk of conversion to full-blown illness," the authors write.

Abstract
Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »